31P Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors

Autor:	L. Musacchio, C. Marchetti, S.M. Boccia, C. Cassani, J. Ventriglia, V. Salutari, F. Camarda, V. Ghizzoni, E. Giudice, M.V. Carbone, S. Pignata, G. Scambia, D. Lorusso
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S396
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::00b878537243145b3f44f0355681f01a https://doi.org/10.1016/j.annonc.2022.04.049 Zobrazit plný text záznamu